Michael F. Mahoney - Sep 7, 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Chairman, President & CEO, Director
Signature
/s/ Vance R. Brown, Attorney-in-fact
Stock symbol
BSX
Transactions as of
Sep 7, 2021
Transactions value $
-$7,624,038
Form type
4
Date filed
9/8/2021, 06:50 PM
Previous filing
Aug 4, 2021
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $848K +135K +6.48% $6.28* 2.22M Sep 7, 2021 Direct F1
transaction BSX Common Stock Options Exercise $488K +66.1K +2.98% $7.39* 2.28M Sep 7, 2021 Direct F1
transaction BSX Common Stock Sale -$8.96M -201K -8.81% $44.57 2.08M Sep 7, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -135K -33.33% $0.00 270K Sep 7, 2021 Common Stock 135K $6.28 Direct F1, F3
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -66.1K -12.5% $0.00 462K Sep 7, 2021 Common Stock 66.1K $7.39 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.34 to $44.71, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F4 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.